section name header

Y-Site Injection Compatibility (1:1 Mixture)

Midazolam HCl

(Mfr: PAN)(Conc: 5 mg/mL)

QMark

Defibrotide sodium

(Mfr: JAZ)(Conc: 8 mg/mLb)

Remarks:

A fine and transient suspension forms within 2.5 hr only when midazolam HCl added to defibrotide; not observed when order of mixing was reversed

Ref:

3149